{"id":188769,"date":"2026-07-02T02:14:12","date_gmt":"2026-07-02T07:44:12","guid":{"rendered":"https:\/\/newslink360.space\/?p=188769"},"modified":"2026-07-02T02:14:12","modified_gmt":"2026-07-02T07:44:12","slug":"extra-medical-moud-use-in-treatment","status":"publish","type":"post","link":"https:\/\/newslink360.space\/?p=188769","title":{"rendered":"Extra-Medical MOUD Use in Treatment"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div>\n<p>    EXTRA-MEDICAL MOUD use was reported at one in 10 treatment visits among urban adults receiving opioid agonist therapy.<\/p>\n<h2>Extra-Medical MOUD Use During Treatment<\/h2>\n<p>Adults receiving prescribed methadone or buprenorphine may still be using medications for <a href=\"https:\/\/www.emjreviews.com\/en-us\/amj\/oncology\/news\/opioid-use-disorder-care-supports-cancer-treatment\/\" target=\"_blank\" rel=\"noopener\">opioid use disorder<\/a> outside formal treatment settings, according to cohort data from 641 adults in Baltimore, Maryland, who had injected drugs and were engaged in treatment.<\/p>\n<p>The analysis included 1,325 visits between January 2023 and December 2024 from participants in the ALIVE cohort who self-reported prescribed or dispensed buprenorphine or methadone use within the past 6 months. Extra-medical MOUD use, defined as use of buprenorphine or methadone in a way not directed by a healthcare provider, was reported at 129 visits, or 10% of all included visits.<\/p>\n<p>At the person level, 117 of 641 participants reported extra-medical MOUD use at least once during the study period, representing 18% of the cohort. Prevalence was 17% among participants receiving only methadone and 21% among those receiving only buprenorphine.<\/p>\n<h2>Treatment Access and Clinical Vulnerability<\/h2>\n<p>The study identified a clear pattern: extra-medical MOUD use was most common among participants with markers of elevated drug-related harm. Use of multiple substances was associated with higher odds of extra-medical MOUD use, as were injection drug use, withdrawal sickness, depressive symptoms, homelessness, incarceration, syringe service program utilization, and carrying naloxone.<\/p>\n<p>The strongest associations included injection drug use, which was linked with nearly sevenfold higher odds, and use of multiple substances, which was linked with more than sixfold higher odds. Withdrawal sickness was also strongly associated with extra-medical MOUD use, supporting the possibility that some adults may be attempting to manage symptoms or treatment gaps despite being formally engaged in care.<\/p>\n<h2>Methadone and Buprenorphine Patterns Differed<\/h2>\n<p>Among participants dispensed methadone, treatment duration appeared important. Those engaged in methadone treatment for at least 6 months had significantly lower odds of extra-medical MOUD use compared with those newly engaged in treatment, even after adjustment for sociodemographic factors, substance use, service utilization, and required opioid treatment program attendance.<\/p>\n<p>By contrast, among participants prescribed buprenorphine, dose rather than treatment duration was associated with extra-medical use. Adults receiving at least 16 mg of sublingual buprenorphine had higher adjusted odds of extra-medical MOUD use than those receiving lower doses.<\/p>\n<p>The authors noted that the findings may reflect unmet treatment needs among adults already receiving medication for opioid use disorder. They emphasized that extra-medical MOUD use may represent concurrent supplementation, use before formal enrollment, replacement during care disruption, or sporadic use across changing treatment circumstances. Further research is needed to clarify motivations and guide policies that shape methadone and buprenorphine access.<\/p>\n<p><strong>Reference<\/strong><br \/>Moon KJ et al. Concurrent Use of Extra-Medical Medication for Opioid Use Disorder Among Adults Prescribed Methadone or Buprenorphine: A Cohort Study of Urban Adults Who Have Injected Drugs. Drug Alcohol Rev. 2026;45(5).<\/p>\n<p>Featured Image: extra-medical MOUD use on Adobe Stock.<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.emjreviews.com\/microbiology-infectious-diseases\/news\/medication-access-may-not-close-opioid-care-gaps\/\" target=\"_blank\" rel=\"noopener\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>EXTRA-MEDICAL MOUD use was reported at one in 10 treatment visits among urban adults receiving opioid agonist therapy. Extra-Medical MOUD Use During Treatment Adults receiving prescribed methadone or buprenorphine may still be using medications for opioid use disorder outside formal treatment settings, according to cohort data from 641 adults in Baltimore, Maryland, who had injected &#8230; <a title=\"Extra-Medical MOUD Use in Treatment\" class=\"read-more\" href=\"https:\/\/newslink360.space\/?p=188769\" aria-label=\"Read more about Extra-Medical MOUD Use in Treatment\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":188770,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7],"tags":[],"class_list":["post-188769","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-national-news"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/newslink360.space\/wp-content\/uploads\/2026\/07\/AdobeStock_1954740664.jpeg","jetpack_likes_enabled":true,"jetpack-related-posts":[{"id":188097,"url":"https:\/\/newslink360.space\/?p=188097","url_meta":{"origin":188769,"position":0},"title":"Cystic Fibrosis Care Still Below Pre-Pandemic Levels","author":"Ajay Kumar Verma","date":"June 30, 2026","format":false,"excerpt":"New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options. RT\u2019s Three Key Takeaways: Care Utilization Gap: Cystic fibrosis care utilization for adults and children remained below 2019 levels through 2023 despite the stabilization of\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/pills-fluorescent-1500.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/pills-fluorescent-1500.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/pills-fluorescent-1500.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/pills-fluorescent-1500.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/pills-fluorescent-1500.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/pills-fluorescent-1500.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":188272,"url":"https:\/\/newslink360.space\/?p=188272","url_meta":{"origin":188769,"position":1},"title":"Review of the American Thoracic Society (ATS) International Conference 2026","author":"Ajay Kumar Verma","date":"July 1, 2026","format":false,"excerpt":"THE American Thoracic Society (ATS) International Conference 2026, held in Orlando, Florida, USA, May 15\u201320, united the pulmonary medicine community for a week of discussion on the latest data, advances, and challenges in respiratory diseases. The meeting themes included the need for more individualized risk prediction, multidisciplinary care, and rehabilitation,\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Respiratory_Congress-review_Review-of-the-american-thoratic-society-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Respiratory_Congress-review_Review-of-the-american-thoratic-society-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Respiratory_Congress-review_Review-of-the-american-thoratic-society-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Respiratory_Congress-review_Review-of-the-american-thoratic-society-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Respiratory_Congress-review_Review-of-the-american-thoratic-society-1.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/Respiratory_Congress-review_Review-of-the-american-thoratic-society-1.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":182013,"url":"https:\/\/newslink360.space\/?p=182013","url_meta":{"origin":188769,"position":2},"title":"Infertility Risk Linked to Delayed Parental Conception","author":"Ajay Kumar Verma","date":"June 18, 2026","format":false,"excerpt":"ADULTS born to parents who took longer to conceive may face a higher risk of infertility themselves, according to findings from a Danish cohort study investigating potential intergenerational patterns of reproductive health.1 The study also found that a maternal history of infertility was linked to a greater likelihood of infertility\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-Repro-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-Repro-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-Repro-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/9am-Repro-1.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":182594,"url":"https:\/\/newslink360.space\/?p=182594","url_meta":{"origin":188769,"position":3},"title":"Hypopigmented Mycosis Fungoides Shows Low Risk","author":"Ajay Kumar Verma","date":"June 19, 2026","format":false,"excerpt":"A LARGE multicentre cohort study has found that hypopigmented mycosis fungoides (HMF) in adults generally follows an indolent clinical course, with most patients presenting with early-stage disease and responding well to skin-directed therapies. Insights from a Multicentre Hypopigmented Mycosis Fungoides Study The retrospective study analysed 224 adults with biopsy-confirmed HMF\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/2pm-derm-5.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":185518,"url":"https:\/\/newslink360.space\/?p=185518","url_meta":{"origin":188769,"position":4},"title":"Hidradenitis Suppurativa and ICIs &#8211; AMJ","author":"Ajay Kumar Verma","date":"June 25, 2026","format":false,"excerpt":"HIDRADENITIS suppurativa may newly develop or flare in some patients receiving immune checkpoint inhibitor therapy. Hidradenitis Suppurativa During Cancer Immunotherapy Immune checkpoint inhibitors have transformed cancer treatment, but their immune-mediated effects can extend beyond tumor control. A new scoping review suggests that hidradenitis suppurativa may emerge after immune checkpoint inhibitor\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/06\/AdobeStock_837966512.jpeg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":188437,"url":"https:\/\/newslink360.space\/?p=188437","url_meta":{"origin":188769,"position":5},"title":"Predicting Pain in Early Rheumatoid Arthritis","author":"Ajay Kumar Verma","date":"July 1, 2026","format":false,"excerpt":"A THIRD of patients still suffer unacceptable pain two years after a rheumatoid arthritis diagnosis, usually with little inflammation to explain it, a 10,000-patient Swedish study finds, pointing to predictors clinicians could spot at diagnosis. Pain in Early Rheumatoid Arthritis Pain that lingers despite controlled inflammation remains a major burden\u2026","rel":"","context":"In &quot;National News&quot;","block_context":{"text":"National News","link":"https:\/\/newslink360.space\/?cat=7"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/3pm-rheum-5.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/3pm-rheum-5.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/3pm-rheum-5.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/newslink360.space\/wp-content\/uploads\/2026\/07\/3pm-rheum-5.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pgnRh4-N6F","_links":{"self":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/188769","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=188769"}],"version-history":[{"count":0,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/posts\/188769\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=\/wp\/v2\/media\/188770"}],"wp:attachment":[{"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=188769"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=188769"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/newslink360.space\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=188769"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}